Your browser doesn't support javascript.
loading
Liquid Biopsy Detects Early Molecular Response and Predicts Benefit to First-Line Chemotherapy plus Cetuximab in Metastatic Colorectal Cancer: PLATFORM-B Study.
Vidal, Joana; Fernández-Rodríguez, Maria Concepción; Casadevall, David; García-Alfonso, Pilar; Páez, David; Guix, Marta; Alonso, Vicente; Cano, Maria Teresa; Santos, Cristina; Durán, Gema; Elez, Elena; Manzano, José Luís; Garcia-Carbonero, Rocío; Ferreiro, Reyes; Losa, Ferran; Pineda, Estela; Sastre, Javier; Rivera, Fernando; Bellosillo, Beatriz; Tabernero, Josep; Aranda, Enrique; Salazar, Ramon; Montagut, Clara.
Afiliação
  • Vidal J; Medical Oncology Department, Hospital del Mar, Institut Mar Investigacions Mèdiques (IMIM), Universitat Pompeu Fabra, CIBERONC, Barcelona, Spain.
  • Fernández-Rodríguez MC; Pathology Department, Hospital del Mar-IMIM, Barcelona, Spain.
  • Casadevall D; Medical Oncology Department, Hospital del Mar, Institut Mar Investigacions Mèdiques (IMIM), Universitat Pompeu Fabra, CIBERONC, Barcelona, Spain.
  • García-Alfonso P; Medical Oncology Department, Hospital Gregorio Marañón, Madrid, Spain.
  • Páez D; Medical Oncology Department, H. Santa Creu i Sant Pau, Barcelona, Spain.
  • Guix M; Medical Oncology Department, Hospital del Mar, Institut Mar Investigacions Mèdiques (IMIM), Universitat Pompeu Fabra, CIBERONC, Barcelona, Spain.
  • Alonso V; Medical Oncology Department, H. Miguel Servet, Zaragoza, Spain.
  • Cano MT; Medical Oncology Department, IMIBIC, Reina Sofía Hospital, University of Cordoba, CIBERONC, Cordoba, Spain.
  • Santos C; Medical Oncology Department, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL)-CIBERONC, Barcelona, Spain.
  • Durán G; Unidad de Gestión Clínica Intercentros de Oncología Médica, Hospitales Universitarios Regional y Virgen de la Victoria, IBIMA, Málaga, Spain.
  • Elez E; Medical Oncology Department, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, CIBERONC, Barcelona, Spain.
  • Manzano JL; Medical Oncology Department, ICO, H. Germans Trias i Pujol, Barcelona, Spain.
  • Garcia-Carbonero R; Medical Oncology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (Imas12), UCM, Madrid, Spain.
  • Ferreiro R; Medical Oncology Department, Hospital Ramón y Cajal, Madrid, Spain.
  • Losa F; Medical Oncology Department, Hospital Sant Joan Despí - Moisès Broggi, ICO-Hospitalet, Barcelona. Spain.
  • Pineda E; Medical Oncology Department Hospital Clínic, Barcelona, Spain.
  • Sastre J; Medical Oncology Department, Hospital Universitario Clínico San Carlos, CIBERONC, Madrid, Spain.
  • Rivera F; Medical Oncology Department Hospital Marqués de Valdecilla, IDIVAL, Santander, Spain.
  • Bellosillo B; Pathology Department, Hospital del Mar-IMIM, Barcelona, Spain.
  • Tabernero J; Medical Oncology Department, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, CIBERONC, Barcelona, Spain.
  • Aranda E; Medical Oncology Department, IMIBIC, Reina Sofía Hospital, University of Cordoba, CIBERONC, Cordoba, Spain.
  • Salazar R; Medical Oncology Department, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL)-CIBERONC, Barcelona, Spain.
  • Montagut C; Medical Oncology Department, Hospital del Mar, Institut Mar Investigacions Mèdiques (IMIM), Universitat Pompeu Fabra, CIBERONC, Barcelona, Spain.
Clin Cancer Res ; 29(2): 379-388, 2023 01 17.
Article em En | MEDLINE | ID: mdl-36074154

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Neoplasias Colorretais / Neoplasias do Colo Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Neoplasias Colorretais / Neoplasias do Colo Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha